- Home
- CATY vs VKTX Comparison
CATY vs VKTX Comparison
Compare CATY & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CATY | VKTX |
|---|---|---|
| Founded | 1962 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.4B |
| IPO Year | 1996 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CATY | VKTX |
|---|---|---|
| Price | $48.95 | $31.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | $52.75 | ★ $88.00 |
| AVG Volume (30 Days) | 338.4K | ★ 2.9M |
| Earning Date | 04-23-2026 | 05-14-2026 |
| Dividend Yield | ★ 2.71% | N/A |
| EPS Growth | ★ 14.94 | N/A |
| EPS | ★ 4.54 | N/A |
| Revenue | ★ $53,793,000.00 | N/A |
| Revenue This Year | $20.37 | N/A |
| Revenue Next Year | $5.41 | N/A |
| P/E Ratio | $11.04 | ★ N/A |
| Revenue Growth | ★ 2.93 | N/A |
| 52 Week Low | $36.06 | $18.92 |
| 52 Week High | $54.99 | $43.15 |
Technical Indicators
Market Signals| Indicator | CATY | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 37.53 | 50.43 |
| Support Level | $48.02 | $30.73 |
| Resistance Level | $49.21 | $35.66 |
| Average True Range (ATR) | 1.46 | 1.85 |
| MACD | -0.54 | 0.39 |
| Stochastic Oscillator | 9.58 | 55.22 |
Price Performance
Historical ComparisonAbout CATY Cathay General Bancorp
Cathay General Bancorp is a regional bank predominantly serving the Chinese-American community. The company's policy is to reach out and actively offer services to low-to-moderate income groups in the delineated branch service areas. It predominantly provides services such as checking and deposit, lines of credits, commercial and commercial real estate loans, merchant services and payment processing, treasury management services, international banking and financing services, and other customary banking services to individuals, professionals, and small to medium-sized businesses. Through its Wealth Management unit, the company also offers investment products and services, such as stocks, bonds, mutual funds, insurance, annuities and advisory services.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.